Tonix Pharmaceuticals Holding (TNXP) Interest & Investment Income: 2017-2023
Historic Interest & Investment Income for Tonix Pharmaceuticals Holding (TNXP) over the last 7 years, with Dec 2023 value amounting to $1.7 million.
- Tonix Pharmaceuticals Holding's Interest & Investment Income rose 6738.89% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 844.22%. This contributed to the annual value of $1.7 million for FY2023, which is 8.06% down from last year.
- According to the latest figures from FY2023, Tonix Pharmaceuticals Holding's Interest & Investment Income is $1.7 million, which was down 8.06% from $1.9 million recorded in FY2022.
- In the past 5 years, Tonix Pharmaceuticals Holding's Interest & Investment Income ranged from a high of $1.9 million in FY2022 and a low of $25,000 during FY2021.
- Over the past 3 years, Tonix Pharmaceuticals Holding's median Interest & Investment Income value was $1.7 million (recorded in 2023), while the average stood at $1.2 million.
- Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 77.14% in 2020, then skyrocketed by 7,392.00% in 2022.
- Yearly analysis of 5 years shows Tonix Pharmaceuticals Holding's Interest & Investment Income stood at $210,000 in 2019, then plummeted by 77.14% to $48,000 in 2020, then crashed by 47.92% to $25,000 in 2021, then spiked by 7,392.00% to $1.9 million in 2022, then dropped by 8.06% to $1.7 million in 2023.